Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox A pseudogene 10 (DUXAP10) is a long non-coding RNA (lncRNA) transcribed from a pseudogene located on chromosome 14q11.2 and is approximately 2398 nucleotides in length[1][2][6]. DUXAP10 does not code for a protein but instead regulates gene expression at the epigenetic and transcriptional level. Its expression is significantly upregulated in several human cancers, and it promotes aggressive tumor phenotypes by enhancing proliferation, cell cycle progression, migration, invasion, and cancer stem cell properties while inhibiting apoptosis[1][2][4][6]. Mechanistically, DUXAP10 functions mainly through its interaction with chromatin modifiers such as LSD1, EZH2, and PRC2 to silence key tumor suppressor genes. Its overexpression correlates with advanced tumor stage, larger tumor size, metastasis, and worse prognosis in multiple cancers, making it both a potential biomarker and a therapeutic target[2][4][6]. No drugs directly targeting DUXAP10 are currently reported, but its inhibition in experimental models reduces tumorigenicity, suggesting translational potential.
Epigenetic silencing via interaction with lysine-specific demethylase 1 (LSD1) and other chromatin-modifying complexes (e.g., PRC2, EZH2); Repression of tumor suppressor genes (e.g., LATS2, RRAD, p21, PTEN) through chromatin modification; Modulation of the PI3K/Akt/mTOR signaling pathway; Interaction with RNA-binding proteins (e.g., HuR)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox A pseudogene 10 (DUXAP10).